Comparing human papillomavirus vaccine concerns on Twitter: A cross-sectional study of users in Australia, Canada and the UK

BMJ Open

Volumn 7, Issue 10, 2017, Pages

  Shapiro, Gilla K ^a,b   Surian, Didi ^c   Dunn, Adam G ^c   Perry, Ryan ^b   Kelaher, Margaret ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Health Belief Model; Human papillomavirus; Social media.; Twitter; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; AUSTRALIA; CANADA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; SOCIAL INTERACTION; SOCIAL MEDIA; UNITED KINGDOM; ATTITUDE TO HEALTH; COMPARATIVE STUDY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VACCINATION;

ATTITUDE TO HEALTH; AUSTRALIA; CANADA; CROSS-SECTIONAL STUDIES; HUMANS; PAPILLOMAVIRUS VACCINES; SOCIAL MEDIA; UNITED KINGDOM; VACCINATION;

EID: 85031086540     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-016869     Document Type: Article

References (91)

1. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24:S1-15.
2. Tota JE, Chevarie-Davis M, Richardson LA, et al. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011;53:S12-21.
3. Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob Health 2016;4:e609-16.
4. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30:F12-23.
5. National Advisory Committee on Immunization. 2012. Update On Human Papillomavirus Vaccines. Canada Communicable Disease. Report. 38.
6. Canadian Cancer Society. Canadian Cancer Statistics, 2016.
7. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2014;63:1-30.
8. Ferris D, Samakoses R, Block SL, et al. Long-term study of a quadrivalent human papillomavirus vaccine. Pediatrics 2014;134:e657-65.
9. Garland SM. The Australian experience with the human papillomavirus vaccine. Clin Ther 2014;36:17-23.
10. Brotherton JM, Saville AM, May CL, et al. Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia. Cancer Causes Control 2015;26:953-4.
11. Brotherton JML, Bloem PJN. HPV vaccination: current global status. Curr Obstet Gynecol Rep 2015;4:220-33.
12. Drolet M, Bénard É, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis 2015;15:565-80.
13. National Health Performance Authority. Healthy Communities: HPV immunisation rates for girls in 2013 (In Focus). 2015.
14. National HPV Vaccination Program Register. National (Australia) HPV 3 dose vaccination coverage for females turning 15 years of age in 2015. 2016.
15. National HPV Vaccination Program Register. National (Australia) HPV 3 dose vaccination coverage for males turning 15 years of age in 2015. 2016.
16. Shapiro GK, Perez S, Rosberger Z. Including males in Canadian human papillomavirus vaccination programs: A policy analysis. CMAJ 2016;188:881-6.
17. Perez S, Shapiro GK, Brown CA, et al. 'I didn't even know boys could get the vaccine': parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons. Psychooncology 2015:1316-23.
18. Perez S, Tatar O, Shapiro GK, et al. Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health 2016;16:1223.
19. Gilbert NL, Gilmour H, Dubé È, et al. Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: results from the Childhood National Immunization Coverage Survey, 2013. Hum Vaccin Immunother 2016;12:1484-90.
20. Vishram B, Byrne L, White J, et al. Human Papillomavirus (HPV) vaccination coverage in adolescent females in England: 2014/15. London, England: Public Health England, 2015.
21. Australian Government Department of Health. Australian Immunisation Register: Current Data. In: Program IA, ed: Commonwealth of Australia; 2017.
22. Screening & Immunisations Team-NHS Digital. NHS Immunisation Statistics England 2015-16, 2016.
23. Government of Canada. Vaccine coverage in Canadian children: highlights from the 2013 childhood National Immunization Coverage Survey (cNICS). 2016.
24. Holman DM, Benard V, Roland KB, et al. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatr 2014;168:76-82.
25. Kumar D, Chandra R, Mathur M, et al. Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res 2016;5.
26. Mason BW, Donnelly PD. Impact of a local newspaper campaign on the uptake of the measles mumps and rubella vaccine. J Epidemiol Community Health 2000;54:473-4.
27. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of antivaccine movements on pertussis control: The untold story. Lancet 1998;351:356-61.
28. Larson HJ, Jarrett C, Schulz WS, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine 2015;33:4165-75.
29. Gollust SE, Attanasio L, Dempsey A, et al. Political and news media factors shaping public awareness of the HPV vaccine. Womens Health Issues 2013;23:e143-51.
30. Hanley SJ, Yoshioka E, Ito Y, et al. HPV vaccination crisis in Japan. Lancet 2015;385:2571.
31. Tiempo E. Caso de ninas del Carmen de Boliìvar desplomoì vacunacioìn contra el VPH. 2015 http://www. eltiempo. com/ estilode-vida/ salud/ vacuna-contra-el-papiloma-humano-cayo-58-puntosporcentuales/ 15246061
32. Gabarron E, Serrano JA, Wynn R, et al. Tweet content related to sexually transmitted diseases: no joking matter. J Med Internet Res 2014;16:e228.
33. Britt RK, Hatten KN, Chappuis SO. Perceived behavioral control, intention to get vaccinated, and usage of online information about the human papillomavirus vaccine. Health Psychol Behav Med 2014;2:52-65.
34. Amicizia D, Domnich A, Gasparini R, et al. An overview of current and potential use of information and communication technologies for immunization promotion among adolescents. Hum Vaccin Immunother 2013;9:2634-42.
35. Betsch C, Renkewitz F, Betsch T, et al. The influence of vaccinecritical websites on perceiving vaccination risks. J Health Psychol 2010;15:446-55.
36. Nan X, Madden K. HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions. Health Commun 2012;27:829-36.
37. Perez S, Fedoruk C, Shapiro GK, et al. Giving boys a shot: The HPV vaccine's portrayal in Canadian newspapers. Health Commun 2016;31:1527-38.
38. Robbins SC, Pang C, Leask J. Australian newspaper coverage of human papillomavirus vaccination, October 2006-December 2009. J Health Commun 2012;17:149-59.
39. Krieger JL, Katz ML, Eisenberg D, et al. Media coverage of cervical cancer and the HPV vaccine: implications for geographic health inequities. Health Expect 2013;16:e1-e12.
40. Quintero Johnson J, Sionean C, Scott AM. Exploring the presentation of news information about the HPV vaccine: A content analysis of a representative sample of U. S. newspaper articles. Health Commun 2011;26:491-501.
41. Habel MA, Liddon N, Stryker JE. The HPV vaccine: A content analysis of online news stories. J Womens Health 2009;18:401-7.
42. Feinberg Y, Pereira JA, Quach S, et al. Understanding public perceptions of the HPV vaccination based on online comments to Canadian news articles. PLoS One 2015;10:e0129587.
43. Coloma PM, Becker B, Sturkenboom MC, et al. Evaluating social media networks in medicines safety surveillance: Two case studies. Drug Saf 2015;38:921-30.
44. Pena MA, Bban A. Dangerous agent or saviour HPV vaccine representations on online discussion forums in Romania. Int J Behav Med 2014;21:20-8.
45. Keelan J, Pavri V, Balakrishnan R, et al. An analysis of the human papilloma virus vaccine debate on MySpace blogs. Vaccine 2010;28:1535-40.
46. Ache KA, Wallace LS. Human papillomavirus vaccination coverage on YouTube. Am J Prev Med 2008;35:389-92.
47. Briones R, Nan X, Madden K, et al. When vaccines go viral: An analysis of HPV vaccine coverage on YouTube. Health Commun 2012;27:478-85.
48. Gunasekaran B, Jayasinghe Y, Fenner Y, et al. Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site. Sex Transm Infect 2013;89:327-9.
49. McNeill A, Harris PR, Briggs P. Twitter influence on UK vaccination and antiviral uptake during the 2009 H1N1 pandemic. Front Public Health 2016;4:26.
50. Bahk CY, Cumming M, Paushter L, et al. Publicly available online tool facilitates real-time monitoring of vaccine conversations and sentiments. Health Aff 2016;35:341-7.
51. Dunn AG, Surian D, Leask J, et al. Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States. Vaccine 2017;35:3033-40.
52. Zhou X, Coiera E, Tsafnat G, et al. Using social connection information to improve opinion mining: identifying negative sentiment about HPV vaccines on Twitter. Stud Health Technol Inform 2015;216:761-5.
53. Mahoney LM, Tang T, Ji K, et al. The digital distribution of public health news surrounding the human papillomavirus vaccination: A longitudinal infodemiology study. JMIR Public Health Surveill 2015;1:e2.
54. Surian D, Nguyen DQ, Kennedy G, et al. Characterizing Twitter discussions about HPV vaccines using topic modeling and community detection. J Med Internet Res 2016;18:e232.
55. Salathé M, Vu DQ, Khandelwal S, et al. The dynamics of health behavior sentiments on a large online social network. EPJ Data Sci 2013;2.
56. Dunn AG, Leask J, Zhou X, et al. Associations between exposure to and expression of negative opinions about human papillomavirus vaccines on social media: An observational study. J Med Internet Res 2015;17:e144.
57. Rosenstock IM. Historical origins of the Health Belief Model. Health Educ Monogr 1974;2:328-35.
58. Donadiki EM, Jiménez-García R, Hernández-Barrera V, et al. Health Belief Model applied to non-compliance with HPV vaccine among female university students. Public Health 2014;128:268-73.
59. Krawczyk A, Knäuper B, Gilca V, et al. Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Hum Vaccin Immunother 2015;11:322-9.
60. Larson H, Leask J, Aggett S, et al. A multidisciplinary research agenda for understanding vaccine-related decisions. Vaccines 2013;1:293-304.
61. Casciotti DM, Smith KC, Tsui A, et al. Discussions of adolescent sexuality in news media coverage of the HPV vaccine. J Adolesc 2014;37:133-43.
62. Casciotti DM, Smith KC, Andon L, et al. Print news coverage of school-based human papillomavirus vaccine mandates. J Sch Health 2014;84:71-81.
63. Madden K, Nan X, Briones R, et al. Sorting through search results: A content analysis of HPV vaccine information online. Vaccine 2012;30:3741-6.
64. Nan X, Daily K. Biased assimilation and need for closure: examining the effects of mixed blogs on vaccine-related beliefs. J Health Commun 2015;20:462-71.
65. Thomson A, Robinson K, Vallée-Tourangeau G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine 2016;34:1018-24.
66. Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. JAMA 2002;287:3245-8.
67. Keelan J, Pavri-Garcia V, Tomlinson G, et al. YouTube as a source of information on immunization: A content analysis. JAMA 2007;298:2481-4.
68. Abdelmutti N, Hoffman-Goetz L. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: A content analysis of Canadian and U. S. national newspaper articles. Women Health 2009;49:422-40.
69. Kata A. A postmodern Pandora's box: Anti-vaccination misinformation on the Internet. Vaccine 2010;28:1709-16.
70. Larson HJ, Wilson R, Hanley S, et al. Tracking the global spread of vaccine sentiments: The global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 2014;10:2543-50.
71. Nyhan B, Reifler J, Richey S, et al. Effective messages in vaccine promotion: A randomized trial. Pediatrics 2014;133:e835-e842.
72. Vishram B, Byrne L, White J, et al. Human Papillomavirus (HPV) vaccination coverage in adolescent females in England: 2014/15. London, England: Public Health England, 2015.
73. Gollust SE, LoRusso SM, Nagler RH, et al. Understanding the role of the news media in HPV vaccine uptake in the United States: synthesis and commentary. Hum Vaccin Immunother 2016;12:1430-4.
74. Betsch C. Social media targeting of health messages. A promising approach for research and practice. Hum Vaccin Immunother 2014;10:2636-7.
75. Bahk CY, Cumming M, Paushter L, et al. Publicly available online tool facilitates real-time monitoring of vaccine conversations and sentiments. Health Aff 2016;35:341-7.
76. Weeg C, Schwartz HA, Hill S, et al. Using Twitter to measure public discussion of diseases: A case study. JMIR Public Health Surveill 2015;1:e6.
77. Pew Research Center. Social networking fact sheet. http://www. pewinternet. org/ fact-sheets/ social-networking-fact-sheet/
78. Radzikowski J, Stefanidis A, Jacobsen KH, et al. The measles vaccination narrative in Twitter: A quantitative analysis. JMIR Public Health Surveill 2016;2:e1.
79. Paul MJ, Dredze M. You are what you tweet: Analyzing Twitter for public health. Association for the Advancement of Artificial Intelligence, 2011.
80. Sadah SA, Shahbazi M, Wiley MT, et al. A study of the demographics of web-based health-related social media users. J Med Internet Res 2015;17:e194.
81. Mislove A, Lehmann S, Ahn Y-Y, et al, 2011. Understanding the demographics of Twitter users. Proceedings of the 5th International AAAI Conference on Weblogs and Social Media
82. Sloan L, Morgan J, Burnap P, et al. Who tweets Deriving the demographic characteristics of age, occupation and social class from Twitter user meta-data. PLoS One 2015;10:e0115545.
83. Sloan L, Morgan J. Who tweets with their location Understanding the relationship between demographic characteristics and the use of geoservices and geotagging on Twitter. PLoS One 2015;10:e0142209.
84. Kumar S, Morstatter F, Marshall G, et al, 2012. Navigating Information Facets on Twitter (NIF-T). Proceedings of the 18th ACM International Conference on Knowledge Discovery and Data Mining (SIGKDD)
85. Kounadi O, Lampoltshammer TJ, Groff E, et al. Exploring Twitter to analyze the public's reaction patterns to recently reported homicides in London. PLoS One 2015;10:e0121848.
86. Elmongui HG, Morsy H, Mansour R, 2015. Inference models for Twitter user's home location prediction. IEEE/ACS International Conference of Computer Systems and Applications
87. Bo H, Paul C, Timothy B. Text-based Twitter user geolocation prediction. J AI Research 2014;49:451-500.
88. Jurgens D, 2013. That's what friends are for: inferring location in online social media platforms based on social relationships. Proceedings of the AAAI International Conference on Weblogs and Social Media (ICWSM)
89. Cheng Z, Caverlee J, Lee K, 2010. You are where you tweet: A content-based approach to geo-locating Twitter users. Proceedings of the 19th ACM International Conference on Information and Knowledge Management
90. Cha M, Haddadi H, Benevenuto F, et al. Measuring user influence in Twitter: The million follower fallacy Association for the Advancement of Artificial Intelligence. 2010.
91. Romero DM, Galuba W, Asur S. Influence and passivity in social media. In: Gunopulos D, Hofmann T, Malerba D, Vazirgiannis M, et al. eds. Machine Learning and Knowledge Discovery in Databases, 2011:18-33.